Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer March 01, 2016 Overview Show transcript Overview Radiation therapy improves survival times in people who are candidates for pancreatic cancer surgery, making it, like chemotherapy, an important addition to treatment. Whether radiation benefits patients after pancreatic cancer surgery has been a long-standing question, and findings from a recent study offer definitive evidence that it does, says Christopher (Chris) L. Hallemeier, M.D., radiation oncologist and senior author of the study. In the future, researchers plan to examine whether radiation is even more beneficial before pancreatic cancer surgery. For more information, see Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer, published in March 2016 in the International Journal of Radiation Oncology, Biology, Physics or Mayo study: Radiation an Important Addition to Treatment for Pancreatic Cancer Surgery Candidates, published on the Mayo Clinic News Network. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticle3 factors associated with improved outcomes for individuals with pancreatic ductal adenocarcinomaArticleEvaluating the safety and diagnostic accuracy of endoscopic fine-needle aspiration for detection of extravascular migratory metastases in the pancreas VID-20439979 Medical Professionals Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer